{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:38:31Z","timestamp":1793752711029,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971645"],"award-info":[{"award-number":["81971645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017689","name":"Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["KY0120211130"],"award-info":[{"award-number":["KY0120211130"]}],"id":[{"id":"10.13039\/501100017689","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application","award":["No. 2022B1212010011"],"award-info":[{"award-number":["No. 2022B1212010011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00277-022-04988-4","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T19:05:38Z","timestamp":1663614338000},"page":"2699-2709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and prognostic role of 2-[18F]FDG PET\/CT and sarcopenia in treatment-na\u00efve patients with T-cell lymphoblastic lymphoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Xiaoyue","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-132X","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"5","key":"4988_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ejh.12722","volume":"96","author":"R Bassan","year":"2016","unstructured":"Bassan R, Maino E, Cortelazzo S (2016) Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol 96(5):447\u2013460","journal-title":"Eur J Haematol"},{"issue":"3","key":"4988_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","volume":"79","author":"S Cortelazzo","year":"2011","unstructured":"Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D (2011) Lymphoblastic lymphoma. Crit Rev Oncol Hematol 79(3):330\u2013343","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"4988_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/PPO.0b013e31826b1232","volume":"18","author":"CA Portell","year":"2012","unstructured":"Portell CA, Sweetenham JW (2012) Adult lymphoblastic lymphoma. Cancer J 18(5):432\u2013438","journal-title":"Cancer J"},{"key":"4988_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exphem.2017.04.002","volume":"51","author":"S Lepretre","year":"2017","unstructured":"Lepretre S, Graux C, Touzart A, Macintyre E, Boissel N (2017) Adult T-type lymphoblastic lymphoma: treatment advances and prognostic indicators. Exp Hematol 51:7\u201316","journal-title":"Exp Hematol"},{"issue":"27","key":"4988_CR5","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048\u20133058","journal-title":"J Clin Oncol"},{"issue":"8","key":"4988_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1182\/blood-2014-12-616474","volume":"126","author":"L Ceriani","year":"2015","unstructured":"Ceriani L, Martelli M, Zinzani PL et al (2015) Utility of baseline 18FDG-PET\/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood 126(8):950\u2013956","journal-title":"Blood"},{"issue":"4","key":"4988_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/annonc\/mdw011","volume":"27","author":"AS Cottereau","year":"2016","unstructured":"Cottereau AS, Becker S, Broussais F et al (2016) Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL). Ann Oncol 27(4):719\u2013724","journal-title":"Ann Oncol"},{"issue":"20","key":"4988_CR8","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood-2017-06-788877","volume":"130","author":"AJ Moskowitz","year":"2017","unstructured":"Moskowitz AJ, Schoder H, Gavane S et al (2017) Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood 130(20):2196\u20132203","journal-title":"Blood"},{"issue":"11","key":"4988_CR9","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00259-014-2822-7","volume":"41","author":"M Sasanelli","year":"2014","unstructured":"Sasanelli M, Meignan M, Haioun C et al (2014) Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 41(11):2017\u20132022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"4988_CR10","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1007\/s00259-017-3776-3","volume":"44","author":"S Becker","year":"2017","unstructured":"Becker S, Vermeulin T, Cottereau AS, Boissel N, Vera P, Lepretre S (2017) Predictive value of (18)F-FDG PET\/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial. Eur J Nucl Med Mol Imaging 44(12):2034\u20132041","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4988_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4143\/crt.2020.123","volume":"53","author":"X Feng","year":"2021","unstructured":"Feng X, Wen X, Li L et al (2021) Baseline total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT predict outcomes in T-cell lymphoblastic lymphoma. Cancer Res Treat 53(3):837\u2013846","journal-title":"Cancer Res Treat"},{"issue":"8","key":"4988_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","volume":"21","author":"S Antoun","year":"2010","unstructured":"Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB (2010) Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21(8):1594\u20131598","journal-title":"Ann Oncol"},{"issue":"4","key":"4988_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(4):601","journal-title":"Age Ageing"},{"issue":"7","key":"4988_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629\u2013635","journal-title":"Lancet Oncol"},{"issue":"22","key":"4988_CR15","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","volume":"15","author":"BH Tan","year":"2009","unstructured":"Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15(22):6973\u20136979","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4988_CR16","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/j.clml.2021.11.006","volume":"22","author":"D Albano","year":"2022","unstructured":"Albano D, Dondi F, Ravanelli M et al (2022) Prognostic role of \u201cradiological\u201d sarcopenia in lymphoma: a systematic review. Clin Lymphoma Myeloma Leuk 22(5):e340\u2013e349","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4988_CR17","doi-asserted-by":"crossref","unstructured":"Albano D, Pasinetti N, Dondi F, Giubbini R, Tucci A, Bertagna F (2022) Prognostic role of pre-treatment metabolic parameters and sarcopenia derived by 2-[(18)F]-FDG PET\/CT in elderly mantle cell lymphoma. J Clin Med 11 (5)","DOI":"10.3390\/jcm11051210"},{"issue":"12","key":"4988_CR18","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00277-015-2499-4","volume":"94","author":"N Nakamura","year":"2015","unstructured":"Nakamura N, Hara T, Shibata Y et al (2015) Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Ann Hematol 94(12):2043\u20132053","journal-title":"Ann Hematol"},{"issue":"4","key":"4988_CR19","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jcsm.12736","volume":"12","author":"VR Zilioli","year":"2021","unstructured":"Zilioli VR, Albano D, Arcari A et al (2021) Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience. J Cachexia Sarcopenia Muscle 12(4):1042\u20131055","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"27","key":"4988_CR20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"issue":"1123","key":"4988_CR21","doi-asserted-by":"publisher","first-page":"20200672","DOI":"10.1259\/bjr.20200672","volume":"94","author":"D Albano","year":"2021","unstructured":"Albano D, Camoni L, Rinaldi R et al (2021) Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of (18)F-FDG PET\/CT in elderly Hodgkin lymphoma patients: a two-centre validation. Br J Radiol 94(1123):20200672","journal-title":"Br J Radiol"},{"issue":"3","key":"4988_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jpen.1721","volume":"44","author":"S Gomez-Perez","year":"2020","unstructured":"Gomez-Perez S, McKeever L, Sheean P (2020) Tutorial: a step-by-step guide (version 2.0) for measuring abdominal circumference and skeletal muscle from a single cross-sectional computed-tomography image using the National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr 44(3):419\u2013424","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"4988_CR23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng X, Shi ZW, Yu JJ et al (2021) Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 12(6):1948\u20131958","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"4988_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.14017","volume":"173","author":"B Burkhardt","year":"2016","unstructured":"Burkhardt B, Mueller S, Khanam T, Perkins SL (2016) Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. Br J Haematol 173(4):545\u2013559","journal-title":"Br J Haematol"},{"issue":"12","key":"4988_CR25","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, Gokbuget N, Digel W et al (2002) Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 99(12):4379\u20134385","journal-title":"Blood"},{"issue":"6","key":"4988_CR26","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","volume":"104","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, O\u2019Brien S, Cortes J et al (2004) Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 104(6):1624\u20131630","journal-title":"Blood"},{"issue":"1","key":"4988_CR27","first-page":"23","volume":"22","author":"A Elhussein","year":"2019","unstructured":"Elhussein A, Fawzy M, Abdel Rahman H, Omar W, Hussein EM (2019) Productivity of 18F-FDG-PET\/CT diagnostic tool in the management of pediatric lymphoblastic lymphoma. Nucl Med Rev Cent East Eur 22(1):23\u201328","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"11","key":"4988_CR28","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1007\/s00259-021-05306-2","volume":"48","author":"JM Gonzalez de Aledo-Castillo","year":"2021","unstructured":"Gonzalez de Aledo-Castillo JM, Casanueva-Eliceiry S, Soler-Perromat A et al (2021) Cell-free DNA concentration and fragment size fraction correlate with FDG PET\/CT-derived parameters in NSCLC patients. Eur J Nucl Med Mol Imaging 48(11):3631\u20133642","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"4988_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","volume":"43","author":"NG Mikhaeel","year":"2016","unstructured":"Mikhaeel NG, Smith D, Dunn JT et al (2016) Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging 43(7):1209\u20131219","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"4988_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00198-009-1059-y","volume":"21","author":"T Lang","year":"2010","unstructured":"Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21(4):543\u2013559","journal-title":"Osteoporos Int"},{"issue":"12","key":"4988_CR31","doi-asserted-by":"publisher","first-page":"e172319","DOI":"10.1001\/jamaoncol.2017.2319","volume":"3","author":"EMC Feliciano","year":"2017","unstructured":"Feliciano EMC, Kroenke CH, Meyerhardt JA et al (2017) Association of Systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319","journal-title":"JAMA Oncol"},{"key":"4988_CR32","doi-asserted-by":"publisher","first-page":"110539","DOI":"10.1016\/j.nut.2019.06.020","volume":"67\u201368","author":"AM Ryan","year":"2019","unstructured":"Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE (2019) Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 67\u201368:110539","journal-title":"Nutrition"},{"issue":"12","key":"4988_CR33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","volume":"34","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA et al (2016) Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol 34(12):1339\u20131344","journal-title":"J Clin Oncol"},{"issue":"9","key":"4988_CR34","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00520-013-1881-9","volume":"21","author":"S Wheelwright","year":"2013","unstructured":"Wheelwright S, Darlington AS, Hopkinson JB, Fitzsimmons D, White A, Johnson CD (2013) A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer 21(9):2625\u20132636","journal-title":"Support Care Cancer"},{"key":"4988_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2016.04.006","volume":"50","author":"T Brioche","year":"2016","unstructured":"Brioche T, Pagano AF, Py G, Chopard A (2016) Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention. Mol Aspects Med 50:56\u201387","journal-title":"Mol Aspects Med"},{"issue":"10191","key":"4988_CR36","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393(10191):2636\u20132646","journal-title":"Lancet"},{"issue":"4","key":"4988_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/10428194.2013.816421","volume":"55","author":"H Lanic","year":"2014","unstructured":"Lanic H, Kraut-Tauzia J, Modzelewski R et al (2014) Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 55(4):817\u2013823","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4988_CR38","first-page":"965","volume":"39","author":"HT Wang","year":"2018","unstructured":"Wang HT, Liu CC, Liu L (2018) New progress in the treatment of T-lymphoblastic lymphoma. Zhonghua Xue Ye Xue Za Zhi 39(11):965\u2013968","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"10","key":"4988_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bbmt.2005.07.001","volume":"11","author":"M Aljurf","year":"2005","unstructured":"Aljurf M, Zaidi SZ (2005) Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies. Biol Blood Marrow Transplant 11(10):739\u2013754","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"4988_CR40","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1002\/cncr.10552","volume":"94","author":"BS Dabaja","year":"2002","unstructured":"Dabaja BS, Ha CS, Thomas DA et al (2002) The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94(10):2738\u20132744","journal-title":"Cancer"},{"issue":"2","key":"4988_CR41","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD et al (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95(2):416\u2013421","journal-title":"Blood"},{"issue":"24","key":"4988_CR42","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","volume":"123","author":"K Beldjord","year":"2014","unstructured":"Beldjord K, Chevret S, Asnafi V et al (2014) Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood 123(24):3739\u20133749","journal-title":"Blood"},{"issue":"6","key":"4988_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","volume":"34","author":"S Lepretre","year":"2016","unstructured":"Lepretre S, Touzart A, Vermeulin T et al (2016) Pediatric-Like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study. J Clin Oncol 34(6):572\u2013580","journal-title":"J Clin Oncol"},{"issue":"34","key":"4988_CR44","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand A, Tanguy-Schmidt A, Ben Abdelali R et al (2013) Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol 31(34):4333\u20134342","journal-title":"J Clin Oncol"},{"issue":"5694","key":"4988_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306(5694):269\u2013271","journal-title":"Science"},{"key":"4988_CR46","doi-asserted-by":"publisher","first-page":"816883","DOI":"10.3389\/fnut.2022.816883","volume":"9","author":"XT Xu","year":"2022","unstructured":"Xu XT, He DL, Tian MX, Wu HJ, Jin X (2022) Prognostic value of sarcopenia in patients with diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis. Front Nutr 9:816883","journal-title":"Front Nutr"},{"issue":"3","key":"4988_CR47","first-page":"161","volume":"13","author":"OB Katz","year":"2011","unstructured":"Katz OB, Ben Barak A, Abrahami G et al (2011) Treatment of T cell lymphoblastic lymphoma in children and adolescents: Israel Society of Pediatric Hematology Oncology retrospective study. Isr Med Assoc J 13(3):161\u2013165","journal-title":"Isr Med Assoc J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04988-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:07:10Z","timestamp":1668190030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4988"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04988-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were approved by the ethics committee at Guangdong Provincial People\u2019s Hospital or The First Affiliated Hospital of Nanjing Medical University, and with the principles of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived due to the retrospective nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}